Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) General Information

Description

Provider of muscular dystrophy therapy services based in Boulder, Colorado. The company specializes in investigational therapy for becker and duchenne, clinical trials of sildenafil in becker and duchenne are ongoing, and to preserve and protect fast muscle fibers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Boulder, CO
  • United States
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Corporate Office
  • Boulder, CO
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)‘s full profile, request access.

Request a free trial

Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)‘s full profile, request access.

Request a free trial

Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) FAQs

  • Where is Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) headquartered?

    Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) is headquartered in Boulder, CO.

  • What industry is Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) in?

    Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)’s primary industry is Laboratory Services (Healthcare).

  • Is Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) a private or public company?

    Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) is a Private company.

  • What is the current valuation of Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)?

    The current valuation of Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) is .

  • What is Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)’s current revenue?

    The current revenue for Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) is .

  • Who are Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)’s investors?

    Edgewise Therapeutics has invested in Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business).

  • When was Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) acquired?

    Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) was acquired on 01-Jun-2026.

  • Who acquired Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)?

    Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) was acquired by Servier.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process